These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9517454)

  • 1. Inhibition of human N-type voltage-gated Ca2+ channels by the neuroprotective agent BW619C89.
    McNaughton NC; Leach MJ; Hainsworth AH; Randall AD
    Neuropharmacology; 1997; 36(11-12):1795-8. PubMed ID: 9517454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of recombinant low-voltage-activated Ca(2+) channels by the neuroprotective agent BW619C89 (Sipatrigine).
    McNaughton NC; Hainsworth AH; Green PJ; Randall AD
    Neuropharmacology; 2000 Apr; 39(7):1247-53. PubMed ID: 10760366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamate.
    Goldin SM; Subbarao K; Sharma R; Knapp AG; Fischer JB; Daly D; Durant GJ; Reddy NL; Hu LY; Magar S
    Ann N Y Acad Sci; 1995 Sep; 765():210-29. PubMed ID: 7486608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+ and Na+ permeability of high-threshold Ca2+ channels and their voltage-dependent block by Mg2+ ions in chick sensory neurones.
    Carbone E; Lux HD; Carabelli V; Aicardi G; Zucker H
    J Physiol; 1997 Oct; 504 ( Pt 1)(Pt 1):1-15. PubMed ID: 9350613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Na+ and high-voltage-activated Ca2+ channel blocking actions of NS-7, a novel neuroprotective agent, in NG108-15 cells.
    Suma C; Hayashi S; Ukai Y; Yoshikuni Y; Kimura K
    Eur J Pharmacol; 1997 Oct; 336(2-3):283-90. PubMed ID: 9384244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State-dependent inhibition of Na+ currents by the neuroprotective agent 619C89 in rat hippocampal neurons and in a mammalian cell line expressing rat brain type IIA Na+ channels.
    Xie XM; Garthwaite J
    Neuroscience; 1996 Aug; 73(4):951-62. PubMed ID: 8809814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89): in vitro and in vivo evidence.
    Callaway JK; Castillo-Melendez M; Giardina SF; Krstew EK; Beart PM; Jarrott B
    Neuropharmacology; 2004 Jul; 47(1):146-55. PubMed ID: 15165842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemia.
    Kawaguchi K; Henshall DC; Simon RP
    Eur J Pharmacol; 1999 Jan; 364(2-3):99-105. PubMed ID: 9932711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage- and use-dependent inhibition of Na+ channels in rat sensory neurones by 4030W92, a new antihyperalgesic agent.
    Trezise DJ; John VH; Xie XM
    Br J Pharmacol; 1998 Jul; 124(5):953-63. PubMed ID: 9692781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuroprotective agent sipatrigine blocks multiple cardiac ion channels and causes triangulation of the ventricular action potential.
    Gao Z; Milnes JT; Choisy SC; Leach MJ; Hancox JC; James AF
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1088-96. PubMed ID: 16445575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels.
    Liu G; Yarov-Yarovoy V; Nobbs M; Clare JJ; Scheuer T; Catterall WA
    Neuropharmacology; 2003 Mar; 44(3):413-22. PubMed ID: 12604088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of magnolol on voltage-gated Na+ and K+ channels of NG108-15 cells.
    Gong CL; Wong KL; Cheng KS; Kuo CS; Chao CC; Tsai MF; Leung YM
    Eur J Pharmacol; 2012 May; 682(1-3):73-8. PubMed ID: 22374258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the inhibition of voltage activated calcium currents in rat cortical neurones by the neuroprotective agent 619C89.
    Stefani A; Hainsworth AH; Spadoni F; Bernardi G
    Br J Pharmacol; 1998 Nov; 125(5):1058-64. PubMed ID: 9846645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.
    Graham SH; Chen J; Lan J; Leach MJ; Simon RP
    J Pharmacol Exp Ther; 1994 May; 269(2):854-9. PubMed ID: 7910213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Ca2+ and Na+ channel inhibitors in vitro and in global cerebral ischaemia in vivo.
    O'Neill MJ; Bath CP; Dell CP; Hicks CA; Gilmore J; Ambler SJ; Ward MA; Bleakman D
    Eur J Pharmacol; 1997 Aug; 332(2):121-31. PubMed ID: 9286613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects.
    Calabresi P; Stefani A; Marfia GA; Hainsworth AH; Centonze D; Saulle E; Spadoni F; Leach MJ; Giacomini P; Bernardi G
    Exp Neurol; 2000 Mar; 162(1):171-9. PubMed ID: 10716897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK.
    Meadows HJ; Chapman CG; Duckworth DM; Kelsell RE; Murdock PR; Nasir S; Rennie G; Randall AD
    Brain Res; 2001 Feb; 892(1):94-101. PubMed ID: 11172753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the neuroprotectant lubeluzole on bovine and mouse chromaffin cell calcium channel subtypes.
    Hernández-Guijo JM; Gandía L; de Pascual R; García AG
    Br J Pharmacol; 1997 Sep; 122(2):275-85. PubMed ID: 9313936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92.
    Caputi L; Hainsworth AH; Lavaroni F; Leach MJ; McNaughton NC; Mercuri NB; Randall AD; Spadoni F; Swan JH; Stefani A
    Brain Res; 2001 Nov; 919(2):259-68. PubMed ID: 11701138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High affinity interaction of mibefradil with voltage-gated calcium and sodium channels.
    Eller P; Berjukov S; Wanner S; Huber I; Hering S; Knaus HG; Toth G; Kimball SD; Striessnig J
    Br J Pharmacol; 2000 Jun; 130(3):669-77. PubMed ID: 10821797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.